: The AMEDEO Literature Guide

Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription

Articles published in J Thorac Oncol
Retrieve available abstracts of 404 articles:
HTML format
Text format

Single Articles

March 2010

ANSEN S , Bangard C, Querings S, Gabler F, et al
Osteoblastic Response in Patients with Non-small Cell Lung Cancer with Activating EGFR Mutations and Bone Metastases during Treatment with EGFR Kinase Inhibitors.
J Thorac Oncol. 2010;5:407-409.
PubMed Text format Related articles

KIM HO , Lee SY, Shim JJ, Kang KH, et al
A Case of Pemetrexed-Induced Acute Lung Injury in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:401-2.
PubMed Text format Related articles

TAKEDA M , Okamoto I, Fujita Y, Arao T, et al
De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in EGFR Mutation-Positive Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2010;5:399-400.
PubMed Text format Related articles Abstract available

DE CABANYES CANDELA S , Detterbeck FC
A Systematic Review of Restaging After Induction Therapy for Stage IIIa Lung Cancer: Prediction of Pathologic Stage.
J Thorac Oncol. 2010;5:389-98.
PubMed Text format Related articles Abstract available

CHIEN CR , Yang ST, Chen CY, Fang HY, et al
Impact of the New Lung Cancer Staging System for a Predominantly Advanced-Disease Patient Population.
J Thorac Oncol. 2010;5:340-343.
PubMed Text format Related articles Abstract available

SUTHERLAND LC , Wang K, Robinson AG
RBM5 as a Putative Tumor Suppressor Gene for Lung Cancer.
J Thorac Oncol. 2010;5:294-298.
PubMed Text format Related articles Abstract available

February 2010

PLUQUET E , Cadranel J, Legendre A, Faller MB, et al
Osteoblastic Reaction in Non-small Cell Lung Carcinoma and its Association to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Response and Prolonged Survival.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SUN JM , Park JO, Won YW, Kim JH, et al
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection of Patients for Maintenance Therapy.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

MAKINSON A , Pujol JL, Le Moing V, Peyriere H, et al
Interactions Between Cytotoxic Chemotherapy and Antiretroviral Treatment in Human Immunodeficiency Virus-Infected Patients with Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LEE HY , Lee HJ, Kim YT, Kang CH, et al
Value of Combined Interpretation of Computed Tomography Response and Positron Emission Tomography Response for Prediction of Prognosis After Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KUBOTA K , Sakai H, Yamamoto N, Kunitoh H, et al
A Multi-Institution Phase I/II Trial of Triweekly Regimen with S-1 Plus Cisplatin in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

YANG CH , Simms L, Park K, Lee JS, et al
Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer: Results of an Exploratory Subgroup Analysis of a Phase III Trial.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SATOUCHI M , Kotani Y, Katakami N, Shimada T, et al
Randomized Phase II Study of Two Different Schedules of Gemcitabine and Oral S-1 in Chemo-naive Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

DOMINIONI L , Rotolo N, Poli A, Paolucci M, et al
Self-Selection Effects in Smokers Attending Lung Cancer Screening: A 9.5-Year Population-Based Cohort Study in Varese, Italy.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

NOVOTNY P , Colligan RC, Szydlo DW, Clark MM, et al
A Pessimistic Explanatory Style Is Prognostic for Poor Lung Cancer Survival.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

ZHAO L , Ji W, Zhang L, Ou G, et al
Changes of Circulating Transforming Growth Factor-beta1 Level During Radiation Therapy Are Correlated with the Prognosis of Locally Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LOPEZ-ENCUENTRA A , Duque-Medina JL, Rami-Porta R
Persistent confusion on the clinical and pathologic nodal staging in lung cancer.
J Thorac Oncol. 2010;5:285-6.
PubMed Text format Related articles

GOFFIN J , Lacchetti C, Ellis PM, Ung YC, et al
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.
J Thorac Oncol. 2010;5:260-74.
PubMed Text format Related articles Abstract available

PETRELLA F , Rizzo S, Solli P, Borri A, et al
Intraparenchymal pulmonary artery aneurysm from ipsilobar non-small cell lung cancer.
J Thorac Oncol. 2010;5:258-9.
PubMed Text format Related articles

SINGH N , Aggarwal AN, Behera D, Jindal SK, et al
Intercycle delays during chemotherapy of non-small cell lung cancer in a health care resource-constrained setting and their effect on overall survival.
J Thorac Oncol. 2010;5:236-9.
PubMed Text format Related articles Abstract available

YU JB , Decker RH, Detterbeck FC, Wilson LD, et al
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer.
J Thorac Oncol. 2010;5:215-9.
PubMed Text format Related articles Abstract available

HOTTA K , Kiura K, Takigawa N, Yoshioka H, et al
Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience.
J Thorac Oncol. 2010;5:179-84.
PubMed Text format Related articles Abstract available

SHEPHERD FA
Surgery for limited stage small cell lung cancer: time to fish or cut bait.
J Thorac Oncol. 2010;5:147-9.
PubMed Text format Related articles

January 2010

CHIAPPORI AA , Zheng Z, Chen T, Rawal B, et al
Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SONG WA , Zhou NK, Wang W, Chu XY, et al
Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

JEON HS , Jen J
TGF-beta Signaling and the Role of Inhibitory Smads in Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

GO H , Jeon YK, Park HJ, Sung SW, et al
High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

LEE YJ , Kim HT, Han JY, Yun T, et al
First-Line Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

SKOV BG , Holm B, Erreboe A, Skov T, et al
ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on Survival.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KIM H , Ahn YC, Park HC, Lim DH, et al
Results and Prognostic Factors of Hypofractionated Stereotactic Radiation Therapy for Primary or Metastatic Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

WU CH , Fan WC, Chen YM, Chou KT, et al
Second-Line Therapy for Elderly Patients with Non-small Cell Lung Cancer Who Failed Previous Chemotherapy Is as Effective as for Younger Patients.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

PARK JS , Yang HC, Kim HK, Kim K, et al
Sleeve Lobectomy as an Alternative Procedure to Pneumonectomy for Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

DHILLON T , Mauri FA, Bellezza G, Cagini L, et al
Overexpression of the Mammalian Target of Rapamycin: A Novel Biomarker for Poor Survival in Resected Early Stage Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

CHIAPPORI A , Bepler G, Barlesi F, Soria JC, et al
Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

KOH Y , Jang B, Han SW, Kim TM, et al
Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

MILLER AA , Pang H, Hodgson L, Ramnath N, et al
A Phase II Study of Dasatinib in Patients with Chemosensitive Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30602).
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

NICHOLSON AG , Gonzalez D, Shah P, Pynegar MJ, et al
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis.
J Thorac Oncol. 2010.
PubMed Text format Related articles Abstract available

COOKE DT , Zheng DJ, Peterson KA, Calhoun RF 2nd, et al
Synchronous pulmonary renal cell carcinoma metastases and primary non-small cell lung cancer.
J Thorac Oncol. 2010;5:140-1.
PubMed Text format Related articles

EDELMAN MJ , Belani CP, Socinski MA, Ansari RH, et al
Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.
J Thorac Oncol. 2010;5:110-6.
PubMed Text format Related articles Abstract available

CENTER B , Petty WJ, Ayala D, Hinson WH, et al
A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and maintenance gefitinib for patients with stage III non-small cell lung cancer.
J Thorac Oncol. 2010;5:69-74.
PubMed Text format Related articles Abstract available

YAMANE Y , Ishii G, Goto K, Kojima M, et al
A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumor.
J Thorac Oncol. 2010;5:49-55.
PubMed Text format Related articles Abstract available

December 2009

OU SH , Ziogas A, Zell JA
A Comparison Study of Clinicopathologic Characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) Patients by Smoking Status.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KIYOHARA C , Horiuchi T, Takayama K, Nakanishi Y, et al
IL1B rs1143634 Polymorphism, Cigarette Smoking, Alcohol Use, and Lung Cancer Risk in a Japanese Population.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

AMANN JM , Lee JW, Roder H, Brahmer J, et al
Genetic and Proteomic Features Associated with Survival after Treatment with Erlotinib in First-Line Therapy of Non-small Cell Lung Cancer in Eastern Cooperative Oncology Group 3503.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

OSAROGIAGBON RU , Allen JW, Farooq A, Berry A, et al
Outcome of Surgical Resection for Pathologic N0 and Nx Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SOCINSKI MA , Scappaticci FA, Samant M, Kolb MM, et al
Safety and Efficacy of Combining Sunitinib with Bevacizumab + Paclitaxel/Carboplatin in Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

DOUILLARD JY , Tribodet H, Aubert D, Shepherd FA, et al
Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

METCALFE SK , Milano MT, Bylund K, Smudzin T, et al
Split-Course Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

CHAPMAN CH , Shen J, Filion EJ, Tran PT, et al
Marked Tumor Response and Fatal Hemoptysis During Radiation for Lung Cancer in a Human Immunodeficiency Virus-Positive Patient Taking Nelfinavir.
J Thorac Oncol. 2009;4:1587-1589.
PubMed Text format Related articles

LIND JS , Postmus PE, Heideman DA, Thunnissen EB, et al
Dramatic Response to Low-Dose Erlotinib of Epidermal Growth Factor Receptor Mutation-Positive Recurrent Non-small Cell Lung Cancer After Severe Cutaneous Toxicity.
J Thorac Oncol. 2009;4:1585-6.
PubMed Text format Related articles Abstract available

KELLY RJ , Hnatiuk O, Giaccone G
Antiangiogenesis induced tumor cavitation in lung cancer.
J Thorac Oncol. 2009;4:1573-5.
PubMed Text format Related articles

SCAGLIOTTI GV , De Marinis F, Rinaldi M, Crino L, et al
The Role of Histology with Common First-line Regimens for Advanced Non-small Cell Lung Cancer: A Brief Report of the Retrospective Analysis of a Three-arm Randomized Trial.
J Thorac Oncol. 2009;4:1568-1571.
PubMed Text format Related articles Abstract available

KAKIHANA M , Ohira T, Chan D, Webster RB, et al
Induction of e-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition.
J Thorac Oncol. 2009;4:1455-65.
PubMed Text format Related articles Abstract available

SOLOMON B , Varella-Garcia M, Camidge DR
ALK Gene Rearrangements: A New Therapeutic Target in a Molecularly Defined Subset of Non-small Cell Lung Cancer.
J Thorac Oncol. 2009;4:1450-4.
PubMed Text format Related articles Abstract available

November 2009

MORGENSZTERN D , Ng SH, Gao F, Govindan R, et al
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

USUDA J , Ichinose S, Ishizumi T, Hayashi H, et al
Management of Multiple Primary Lung Cancer in Patients with Centrally Located Early Cancer Lesions.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

CLEMENT-DUCHENE C , Wakelee H
Antiangiogenic Agents and Vascular Disrupting Agents for the Treatment of Lung Cancer: A Review.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

PAYNE M , Bradbury P, Lang B, Vincent A, et al
Prospective Study into the Incidence of Lambert Eaton Myasthenic Syndrome in Small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SUBRAMANIAN J , Morgensztern D, Goodgame B, Baggstrom MQ, et al
Distinctive Characteristics of Non-small Cell Lung Cancer (NSCLC) in the Young: A Surveillance, Epidemiology, and End Results (SEER) Analysis.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

BOYD JA , Hubbs JL, Kim DW, Hollis D, et al
Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KIM HK , Choi YS, Kim J, Shim YM, et al
Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar Carcinoma.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

YOON KA , Gil HJ, Han J, Park J, et al
Genetic Polymorphisms in the Polycomb Group Gene EZH2 and the Risk of Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

YOSHIOKA H , Hotta K, Kiura K, Takigawa N, et al
A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

IRION KL , Fewins H, Binukrishnan S
Comments on the proposed new international lymph node International Association for the Study of Lung Cancer map.
J Thorac Oncol. 2009;4:1445.
PubMed Text format Related articles

LIM E , Harris G, Patel A, Adachi I, et al
Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials.
J Thorac Oncol. 2009;4:1380-8.
PubMed Text format Related articles Abstract available

KOIKE T , Yamato Y, Asamura H, Tsuchiya R, et al
Improvements in surgical results for lung cancer from 1989 to 1999 in Japan.
J Thorac Oncol. 2009;4:1364-9.
PubMed Text format Related articles Abstract available

PASTORINO U , Landoni C, Marchiano A, Calabro E, et al
Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.
J Thorac Oncol. 2009;4:1352-6.
PubMed Text format Related articles Abstract available

BECHTEL JJ , Kelley WA, Coons TA, Mohler P, et al
Five-year outcome of lung cancer detection in patients with and without airflow obstruction in a primary care outpatient practice.
J Thorac Oncol. 2009;4:1347-51.
PubMed Text format Related articles Abstract available

YANG HX , Hou X, Lin P, Yang H, et al
Peripheral direct adjacent lobe invasion non-small cell lung cancer has a similar survival to that of parietal pleural invasion T3 disease.
J Thorac Oncol. 2009;4:1342-6.
PubMed Text format Related articles Abstract available

GOULD MK
Delays in lung cancer care: time to improve.
J Thorac Oncol. 2009;4:1303-4.
PubMed Text format Related articles

SOMAIAH N , Simon GR
Molecular targeted therapy in non-small cell lung cancer: an overview of available agents.
J Thorac Oncol. 2009;4.
PubMed Text format Related articles

GOVINDAN R
Summary of presentations from the Ninth Annual Targeted Therapies in Lung Cancer Symposium.
J Thorac Oncol. 2009;4.
PubMed Text format Related articles

October 2009

NAIR VS , Krupitskaya Y, Gould MK
Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer:: A Systematic Review.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

REYNOLDS C , Barrera D, Jotte R, Spira AI, et al
Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

GIRARD N , Jacoulet P, Gainet M, Elleuch R, et al
Third-Line Chemotherapy in Advanced Non-small Cell Lung Cancer: Identifying the Candidates for Routine Practice.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

MACK PC , Holland WS, Burich RA, Sangha R, et al
EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

EDELMAN MJ , Clamon G, Kahn D, Magram M, et al
Targeted Radiopharmaceutical Therapy for Advanced Lung Cancer: Phase I Trial of Rhenium Re188 P2045, a Somatostatin Analog.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KANEDA H , Okamoto I, Hayashi H, Yoshioka H, et al
Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401).
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

MANDREKAR SJ , Qi Y, Hillman SL, Ziegler KL, et al
Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

YANO T , Morodomi Y, Ito K, Yoshida T, et al
Verification of the Newly Proposed T Category (Seventh Edition of the Tumor, Node, and Metastasis Classification) from a Clinicopathological Viewpoint in Non-small Cell Lung Cancer-Special Reference to Tumor Size.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

CHEN KY , Chen JH, Shih JY, Yang CH, et al
Octogenarians with Advanced Non-small Cell Lung Cancer: Treatment Modalities, Survival, and Prognostic Factors.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

HARDY D , Cormier JN, Xing Y, Liu CC, et al
Chemotherapy-Associated Toxicity in a Large Cohort of Elderly Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

TOURNOY KG , Annema JT, Krasnik M, Herth FJ, et al
Endoscopic and Endobronchial Ultrasonography According to the Proposed Lymph Node Map Definition in the Seventh Edition of the Tumor, Node, Metastasis Classification for Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

D'ANGELILLO RM , Trodella L, Ciresa M, Cellini F, et al
Multimodality Treatment of Stage III Non-small Cell Lung Cancer: Analysis of a Phase II Trial Using Preoperative Cisplatin and Gemcitabine with Concurrent Radiotherapy.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SPIGEL DR , Greco FA, Zubkus JD, Murphy PB, et al
Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

HAMADA C , Tsuboi M, Ohta M, Fujimura S, et al
Effect of Postoperative Adjuvant Chemotherapy with Tegafur-Uracil on Survival in Patients with Stage IA Non-small Cell Lung Cancer: An Exploratory Analysis from a Meta-Analysis of Six Randomized Controlled Trials.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

NAKANISHI R , Yamashita T, Oka S
Video-Assisted Thoracic Surgery Lobectomy for Non-small Cell Lung Cancer in Patients with a Charlson Comorbidity Index Score of Two or More.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

September 2009

KLEIN R , Muehlenbein C, Liepa AM, Babineaux S, et al
Cost-Effectiveness of Pemetrexed Plus Cisplatin as First-Line Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KUBOTA K , Niho S, Enatsu S, Nambu Y, et al
Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Review of Results from an Open-Label Randomized Phase II Study.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

BODTGER U , Vilmann P, Clementsen P, Galvis E, et al
Clinical Impact of Endoscopic Ultrasound-Fine Needle Aspiration of Left Adrenal Masses in Established or Suspected Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

MORGENSZTERN D , Waqar S, Subramanian J, Gao F, et al
Improving Survival for Stage IV Non-small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Survey from 1990 to 2005.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

YORIO JT , Xie Y, Yan J, Gerber DE, et al
Lung Cancer Diagnostic and Treatment Intervals in the United States: A Health Care Disparity?
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

THIBOUT Y , Guibert B, Bossard N, Tronc F, et al
Is Pneumonectomy After Induction Chemotherapy for Non-small Cell Lung Cancer a Reasonable Procedure? A Multicenter Retrospective Study of 228 Cases.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KANG CH , Jang BG, Kim DW, Jeong DH, et al
Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and betaIII-Tubulin Between Primary Non-small Cell Lung Cancer and Metastatic Lymph Nodes and the Significance in Mid-Term
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

WHITE DA , Schwartz LH, Dimitrijevic S, Scala LD, et al
Characterization of Pneumonitis in Patients with Advanced Non-small Cell Lung Cancer Treated with Everolimus (RAD001).
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

MASSARD C , Ba Loc PT, Haddad V, Pignon JP, et al
Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ZHAO J , Li H, Wang M
Acute renal failure in a patient receiving anti-VEGF therapy for advanced non-small cell lung cancer.
J Thorac Oncol. 2009;4:1185-7.
PubMed Text format Related articles

SEQUIST LV , Fidias P, Heist RS, Ostler P, et al
Brief report of biweekly pemetrexed and gemcitabine in elderly patients with non-small cell lung cancer.
J Thorac Oncol. 2009;4:1170-3.
PubMed Text format Related articles Abstract available

LEIGHL NB , Laurie SA, Chen XE, Ellis P, et al
A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortium.
J Thorac Oncol. 2009;4:1163-9.
PubMed Text format Related articles Abstract available

FIDIAS P , Pennell NA, Boral AL, Shapiro GI, et al
Phase I study of the c-raf-1 antisense oligonucleotide ISIS 5132 in combination with carboplatin and paclitaxel in patients with previously untreated, advanced non-small cell lung cancer.
J Thorac Oncol. 2009;4:1156-62.
PubMed Text format Related articles Abstract available

HERTH FJ , Eberhardt R, Anantham D, Gompelmann D, et al
Narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection.
J Thorac Oncol. 2009;4:1060-5.
PubMed Text format Related articles Abstract available

WEST HL , Garfield DH
Bronchioloalveolar carcinoma: not as easy as "BAC".
J Thorac Oncol. 2009;4:1047-8.
PubMed Text format Related articles

WEST H , Lilenbaum R, Harpole D, Wozniak A, et al
Molecular analysis-based treatment strategies for the management of non-small cell lung cancer.
J Thorac Oncol. 2009;4.
PubMed Text format Related articles Abstract available

Abstracts of the 13th World Conference on Lung Cancer.
J Thorac Oncol. 2009;4.
PubMed Text format Related articles

August 2009

OU SH , Zell JA
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

JALAL S , Waterhouse D, Edelman MJ, Nattam S, et al
Pemetrexed plus Cetuximab in Patients with Recurrent Non-small Cell Lung Cancer (NSCLC): A Phase I/II Study from the Hoosier Oncology Group.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

DE MARINIS F , Eberhardt W, Harper PG, Sureda BM, et al
Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

NIEDER C , Bremnes RM, Andratschke NH
Prognostic Scores in Patients with Brain Metastases from Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SEQUIST LV , Fidias PM, Temel JS, Kolevska T, et al
Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

UM SW , Kim H, Koh WJ, Suh GY, et al
Prognostic Value of 18F-FDG Uptake on Positron Emission Tomography in Patients with Pathologic Stage I Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

LIU SF , Zhang S, Chen YC, Fang WF, et al
Experience of Cancer Care for Metastasis-Induced Acute Pancreatitis Patients with Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

GOODGAME B , Viswanathan A, Zoole J, Gao F, et al
Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger Patients.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ZHAN P , Wang J, Lv XJ, Wang Q, et al
Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

UHM JE , Park BB, Ahn MJ, Lee J, et al
Erlotinib Monotherapy for Stage IIIB/IV Non-small Cell Lung Cancer: A Multicenter Trial by the Korean Cancer Study Group.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KIM HK , Choi YS, Kim K, Shim YM, et al
Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-Small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

GOMEZ-ROCA C , Raynaud CM, Penault-Llorca F, Mercier O, et al
Differential Expression of Biomarkers in Primary Non-small Cell Lung Cancer and Metastatic Sites.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ARRIETA O , Rios Trejo MA, Michel RM
Wood-smoke exposure as a response and survival predictor in erlotinib-treated nonsmall cell lung cancer patients.
J Thorac Oncol. 2009;4:1043.
PubMed Text format Related articles

DOOMS C , Vansteenkiste J, Van Renterghem D, De Leyn P, et al
Esophageal ultrasound-controlled fine needle aspiration for staging of mediastinal lymph nodes in patients with resectable lung cancer: do we always see the reality?
J Thorac Oncol. 2009;4:1043-5.
PubMed Text format Related articles

SINGH N , Aggarwal AN
ERCC1 and RRM1 Expression in nonsmall cell lung cancer--the good, the bad and the unknown.
J Thorac Oncol. 2009;4:1042-3.
PubMed Text format Related articles

QUOIX E
Prognostic factors for survival in extensive stage small cell lung cancer.
J Thorac Oncol. 2009;4:1041.
PubMed Text format Related articles

VORONEY JP , Hope A, Dahele MR, Purdy T, et al
Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer.
J Thorac Oncol. 2009;4:1035-7.
PubMed Text format Related articles Abstract available

LYNCH TJ , Fenton D, Hirsh V, Bodkin D, et al
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer.
J Thorac Oncol. 2009;4:1002-9.
PubMed Text format Related articles Abstract available

TSUJINO K , Kawaguchi T, Kubo A, Aono N, et al
Response rate is associated with prolonged survival in patients with advanced non-small cell lung cancer treated with gefitinib or erlotinib.
J Thorac Oncol. 2009;4:994-1001.
PubMed Text format Related articles Abstract available

STEPHANS KL , Djemil T, Reddy CA, Gajdos SM, et al
A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.
J Thorac Oncol. 2009;4:976-82.
PubMed Text format Related articles Abstract available

DUDEK AZ , Lesniewski-Kmak K, Larson T, Dragnev K, et al
Phase II trial of neoadjuvant therapy with carboplatin, gemcitabine plus thalidomide for stages IIB and III non-small cell lung cancer.
J Thorac Oncol. 2009;4:969-75.
PubMed Text format Related articles Abstract available

THUNNISSEN FB
Acetylcholine receptor pathway and lung cancer.
J Thorac Oncol. 2009;4:943-6.
PubMed Text format Related articles Abstract available

JEREMIC B
Activities in the field of lung cancer coordinated by the section of applied radiation biology And Radiotherapy of the International Atomic Energy Agency.
J Thorac Oncol. 2009;4:941-2.
PubMed Text format Related articles

PENA T , LoRusso PM, Ruckdeschel JC, Goncalves P, et al
Pulmonary metastasis of basal cell carcinoma: a rare manifestation of a common disease with variable clinical course.
J Thorac Oncol. 2009;4:1026-7.
PubMed Text format Related articles

YANAGAWA J , Abtin F, Lai CK, Yeh M, et al
Resection of thyroid cancer metastases to the sternum.
J Thorac Oncol. 2009;4:1022-5.
PubMed Text format Related articles Abstract available

GOLDSTRAW P , Rami-Porta R, Crowley J
We probably have the answer: now what is the question?
J Thorac Oncol. 2009;4:939-40.
PubMed Text format Related articles

ERNST A , Eberhardt R, Krasnik M, Herth FJ, et al
Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer.
J Thorac Oncol. 2009;4:947-50.
PubMed Text format Related articles Abstract available

JIN J , Xu X, Wang F, Yan G, et al
Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.
J Thorac Oncol. 2009;4:1017-21.
PubMed Text format Related articles Abstract available

July 2009

OU SH , Ziogas A, Zell JA
Asian Ethnicity Is a Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer (NSCLC) and Is Independent of Smoking Status.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

STINCHCOMBE TE , Hodgson L, Herndon JE 2nd, Kelley MJ, et al
Treatment Outcomes of Different Prognostic Groups of Patients on Cancer and Leukemia Group B Trial 39801: Induction Chemotherapy Followed by Chemoradiotherapy Compared with Chemoradiotherapy Alone for Unresectable Stage III Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

VALLIRES E , Shepherd FA, Crowley J, Van Houtte P, et al
The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KASHIHARA M , Azuma K, Kawahara A, Basaki Y, et al
Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

DOOMS C , Verbeken E, Stroobants S, Vansteenkiste J, et al
Biological Correlates of the Maximum 18-Fluoro-2-Deoxy-Glucose Uptake on Positron Emission Tomography in Non-small Cell Lung Carcinoma after Induction Chemotherapy.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SCHWARTZ AG , Cote ML, Wenzlaff AS, Land S, et al
Racial Differences in the Association Between SNPs on 15q25.1, Smoking Behavior, and Risk of Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

POP D , Nadeemy AS, Venissac N, Guiraudet P, et al
Skeletal Muscle Metastasis from Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ISA SI , Kawaguchi T, Teramukai S, Minato K, et al
Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer: Results from JMTO LC 0004.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KASHIWABARA K , Sasaki JI, Mori T, Nomori H, et al
Relationship Between Functional Preservation after Segmentectomy and Volume-Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients with Emphysema.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

OKAMI J , Higashiyama M, Asamura H, Goya T, et al
Pulmonary Resection in Patients Aged 80 Years or Over with Clinical Stage I Non-small Cell Lung Cancer: Prognostic Factors for Overall Survival and Risk Factors for Postoperative Complications.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

BINDER D , Hackenthal M, Graseck L, Schweisfurth H, et al
A Phase II Study of Weekly Docetaxel-Cisplatin As First-Line Treatment for Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

BENEDETTI G , Latini L, Galetta D, Colucci G, et al
Epidermal growth factor receptor exon 19 deletions predict complete regression of multiple intracranial metastases in two cases of non-small cell lung cancer treated with erlotinib.
J Thorac Oncol. 2009;4:936-7.
PubMed Text format Related articles

CAMIDGE R , Gaspar L, Goss G, Kelly K, et al
Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium.
J Thorac Oncol. 2009;4:930-5.
PubMed Text format Related articles Abstract available

GOTO Y , Sekine I, Sekiguchi H, Yamada K, et al
Differences in the quality of information on the internet about lung cancer between the United States and Japan.
J Thorac Oncol. 2009;4:829-33.
PubMed Text format Related articles Abstract available

SOLOMON B , Pearson RB
Class IA phosphatidylinositol 3-kinase signaling in non-small cell lung cancer.
J Thorac Oncol. 2009;4:787-91.
PubMed Text format Related articles

ZELL JA , Ignatius Ou SH
Survival prognostication in non-small cell lung cancer.
J Thorac Oncol. 2009;4:785-6.
PubMed Text format Related articles

BRADLEY J
So far, so good for lung cancer SBRT.
J Thorac Oncol. 2009;4:781-2.
PubMed Text format Related articles

CADRANEL J , Quoix E, Baudrin L, Mourlanette P, et al
IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

TAGAWA T , Takasu M, Ishida T
Asymptomatic air embolism after computed tomography-guided lung needle marking.
J Thorac Oncol. 2009;4:937-8.
PubMed Text format Related articles

VAN DEN HEUVEL DA , Keijsers RG, van Es HW, Bootsma GP, et al
Invasive inflammatory myofibroblastic tumor of the lung.
J Thorac Oncol. 2009;4:923-6.
PubMed Text format Related articles Abstract available

URPEK G , Susam S, Tulumen R, Yilmaz U, et al
A pericardiophrenic vein varix mimicking a pulmonary mass.
J Thorac Oncol. 2009;4:889-90.
PubMed Text format Related articles

URBANIC JJ , Lally B, Blackstock AW
"The best-laid plans ... often go awry ...".
J Thorac Oncol. 2009;4:783-4.
PubMed Text format Related articles

DAVIES AM , Ho C, Beckett L, Lau D, et al
Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separation.
J Thorac Oncol. 2009;4:862-8.
PubMed Text format Related articles Abstract available

June 2009

GREEN MR , West H, Socinski MA, Willey J, et al
Impact of the ASCO 2007 Presentation of HOG Lun 01-24/USO-023 on the Prescribing Plans of American Medical Oncologists for Patients with Stage IIIB Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

THAM CK , Choo SP, Lim WT, Toh CK, et al
Gefitinib in Combination with Gemcitabine and Carboplatin in Never Smokers with Non-small Cell Lung Carcinoma: A Retrospective Analysis.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ZWITTER M , Kovac V, Smrdel U, Vrankar M, et al
Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II Clinical Trial.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

QI Y , Schild SE, Mandrekar SJ, Tan AD, et al
Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ANAMI Y , Iijima T, Suzuki K, Yokota J, et al
Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

NAVANI N , Spiro SG, Janes SM
EBUS-TBNA for the mediastinal staging of non-small cell lung cancer.
J Thorac Oncol. 2009;4:776.
PubMed Text format Related articles

FLOOD TA , Sekhon HS, Seely JM, Shamji FM, et al
Spontaneous pneumothorax and lung carcinoma: should one consider synchronous malignant pleural mesothelioma?
J Thorac Oncol. 2009;4:770-2.
PubMed Text format Related articles Abstract available

GIROUX DJ , Rami-Porta R, Chansky K, Crowley JJ, et al
The IASLC Lung Cancer Staging Project: data elements for the prospective project.
J Thorac Oncol. 2009;4:679-83.
PubMed Text format Related articles Abstract available

PIO R , Montuenga LM
Alternative splicing in lung cancer.
J Thorac Oncol. 2009;4:674-8.
PubMed Text format Related articles Abstract available

GOLDSTRAW P
The 7th Edition of TNM in Lung Cancer: what now?
J Thorac Oncol. 2009;4:671-3.
PubMed Text format Related articles

IGAWA S , Murakami H, Yamamoto N
Thymic small cell carcinoma shows marked response to amrubicin.
J Thorac Oncol. 2009;4:778.
PubMed Text format Related articles

SHIGEMATSU H , Andou A, Matsuo K
Pulmonary tumor embolism.
J Thorac Oncol. 2009;4:777.
PubMed Text format Related articles

QIAO GB , Zeng WS, Peng LJ, Zhong WZ, et al
Multiple pulmonary chondromas in a young female patient: a component of Carney triad.
J Thorac Oncol. 2009;4:751-2.
PubMed Text format Related articles

TAMMEMAGI MC , Freedman MT, Pinsky PF, Oken MM, et al
Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study.
J Thorac Oncol. 2009;4:710-21.
PubMed Text format Related articles Abstract available

YAMAMOTO N , Nambu Y, Fujimoto T, Koshiji M, et al
A landmark point analysis with cytotoxic agents for advanced NSCLC.
J Thorac Oncol. 2009;4:697-701.
PubMed Text format Related articles Abstract available

May 2009

PARK S , Holmes-Tisch AJ, Cho EY, Shim YM, et al
Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KEPKA L , Tyc-Szczepaniak D, Bujko K
Dose-per-Fraction Escalation of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy in Locally Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

DOOMS C , van Baardwijk A, Verbeken E, van Suylen RJ, et al
Association Between 18F-Fluoro-2-Deoxy-d-Glucose Uptake Values and Tumor Vitality: Prognostic Value of Positron Emission Tomography in Early-Stage Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ARRIETA O , Gallardo-Rincon D, Villarreal-Garza C, Michel RM, et al
High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine after Induction with Gemcitabine and Carboplatin.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

LEE DH , Kim SK, Lee HY, Lee SY, et al
Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

STEPHANS KL , Djemil T, Reddy CA, Gajdos SM, et al
Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

LILENBAUM R , Villaflor VM, Langer C, O'Byrne K, et al
Single-Agent Versus Combination Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: Prognostic Factors and Treatment Selection Based on Two Large Randomized Clinical Trials.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

CHANSKY K , Sculier JP, Crowley JJ, Giroux D, et al
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

HANAGIRI T , Sugio K, Baba T, Ichiki Y, et al
Results of Surgical Treatment for Patients With Small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

WU X , Piper-Hunter MG, Crawford M, Nuovo GJ, et al
MicroRNAs in the Pathogenesis of Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

YOSHIDA J , Nagai K, Asamura H, Goya T, et al
Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival: Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

CUSTODIO AB , Gonzalez-Larriba JL, Bobokova J, Calles A, et al
Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

RUCO L , Scarpino S, Natoli G
Validation of a reverse transcription-polymerase chain reaction-based five-gene signature in non-small cell lung cancer.
J Thorac Oncol. 2009;4:670.
PubMed Text format Related articles

DEBEVEC L
Is it time to reevaluate the role of surgery in small cell lung cancer?
J Thorac Oncol. 2009;4:669.
PubMed Text format Related articles

VIDAVER RM , Schachter BS
2008 Meeting of the National Lung Cancer Partnership: a summary of meeting highlights.
J Thorac Oncol. 2009;4:666-8.
PubMed Text format Related articles Abstract available

GEORGE B , Wirostko WJ, Connor TB, Choong NW, et al
Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy.
J Thorac Oncol. 2009;4:661-2.
PubMed Text format Related articles Abstract available

NACKAERTS K , Vansteenkiste J
Low-dose CT screening for lung cancer: trial and error?
J Thorac Oncol. 2009;4:563-4.
PubMed Text format Related articles

SEOL HJ , Lee JH, Lee KY, Kim JH, et al
Primary pulmonary choriocarcinoma presenting with a hemothorax.
J Thorac Oncol. 2009;4:663-5.
PubMed Text format Related articles Abstract available

REICHERT M , Bensadoun ES
PET imaging in patients with coal workers pneumoconiosis and suspected malignancy.
J Thorac Oncol. 2009;4:649-51.
PubMed Text format Related articles Abstract available

VAN SCHIL PE
From individual lymph nodes to stations and zones: East and West reconciled?
J Thorac Oncol. 2009;4:561-2.
PubMed Text format Related articles

LANS TE , van der Pol C, Wouters MW, Schmitz PI, et al
Complications in wound healing after chest wall resection in cancer patients; a multivariate analysis of 220 patients.
J Thorac Oncol. 2009;4:639-43.
PubMed Text format Related articles Abstract available

KURATA T , Kashii T, Takeda K, Seki N, et al
A phase I study of topotecan plus carboplatin for relapsed SCLC: WJTOG trial.
J Thorac Oncol. 2009;4:644-8.
PubMed Text format Related articles Abstract available

KAWACHI R , Watanabe S, Asamura H
Clinicopathological characteristics of screen-detected lung cancers.
J Thorac Oncol. 2009;4:615-9.
PubMed Text format Related articles Abstract available

WINGET M , Stanger J, Gao Z, Butts C, et al
Predictors of surgery and consult with an oncologist for adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada.
J Thorac Oncol. 2009;4:629-34.
PubMed Text format Related articles Abstract available

April 2009

SCHUURBIERS OC , Kaanders JH, van der Heijden HF, Dekhuijzen RP, et al
The PI3-K/AKT-Pathway and Radiation Resistance Mechanisms in Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SCHALLIER D , Bral S, Ilsen B, Neyns B, et al
Final Overall Results of a Study with a Novel Triplet Induction Chemotherapy Regimen (PACCAGE) Followed by Consolidation Radiotherapy in Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC).
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

DANIELE L , Cassoni P, Bacillo E, Cappia S, et al
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

LI Z , Yu Y, Lu J, Luo Q, et al
Analysis of the T Descriptors and Other Prognosis Factors in Pathologic Stage I Non-Small Cell Lung Cancer in China.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SALMON S , Chen H, Chen S, Herbst R, et al
Classification by Mass Spectrometry Can Accurately and Reliably Predict Outcome in Patients with Non-small Cell Lung Cancer Treated with Erlotinib-Containing Regimen.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

JAIN AK , Hughes RS, Sandler AB, Dowlati A, et al
A Phase II Study of Concurrent Chemoradiation with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC).
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

FUKUDA M , Nakamura Y, Kasai T, Nagashima S, et al
A Phase I Study of Amrubicin and Carboplatin for Previously Untreated Patients with Extensive-Disease Small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

GATZEMEIER U , Ciuleanu T, Dediu M, Ganea-Motan E, et al
XM02, the First Biosimilar G-CSF, is Safe and Effective in Reducing the Duration of Severe Neutropenia and Incidence of Febrile Neutropenia in Patients with Small Cell or Non-small Cell Lung Cancer Receiving Platinum-Based Chemotherapy.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

WATANABE SI , Asamura H
Lymph Node Dissection for Lung Cancer: Significance, Strategy, and Technique.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ROBERTS HC , Patsios DA, Paul NS, Deperrot M, et al
Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

LE MAITRE A , Ding K, Shepherd FA, Leighl N, et al
Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

PUJOL JL , Quantin X, Chakra M
Cardiorespiratory Fitness in Patients with Advanced Non-small Cell Lung Cancer: Why is this Feature Important to Evaluate? Can it be Improved?
J Thorac Oncol. 2009.
PubMed Text format Related articles

RUSCH VW , Asamura H, Watanabe H, Giroux DJ, et al
The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

PEDERSEN JH , Ashraf H, Dirksen A, Bach K, et al
The Danish Randomized Lung Cancer CT Screening Trial-Overall Design and Results of the Prevalence Round.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

MATHEW J , Kratzke RA
Lung Cancer and Lung Transplantation: A Review.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

AZIM HA JR , Scarfone G, Peccatori FA
Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancy.
J Thorac Oncol. 2009;4:559-60.
PubMed Text format Related articles

GUANDALINI M , Steinke K, Francesconi A
Pulmonary metastases from cervical adenocarcinoma regress to a 'hole' lot of nothing.
J Thorac Oncol. 2009;4:552-4.
PubMed Text format Related articles Abstract available

BABU KS , Roberts F, Bryden F, McCafferty A, et al
Metastases to breast from primary lung cancer.
J Thorac Oncol. 2009;4:540-2.
PubMed Text format Related articles Abstract available

DETTERBECK FC , Tanoue LT, Boffa DJ
Anatomy, biology and concepts, pertaining to lung cancer stage classification.
J Thorac Oncol. 2009;4:437-43.
PubMed Text format Related articles Abstract available

TRAYNOR AM , Dubey S, Eickhoff JC, Kolesar JM, et al
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study.
J Thorac Oncol. 2009;4:522-6.
PubMed Text format Related articles Abstract available

SEKINE I , Nokihara H, Yamamoto N, Kunitoh H, et al
Comparative chemotherapeutic efficacy in non-small cell lung cancer patients with postoperative recurrence and stage IV disease.
J Thorac Oncol. 2009;4:518-21.
PubMed Text format Related articles Abstract available

HAN K , Cao W, Che J, Bo S, et al
First line chemotherapy with weekly docetaxel and cisplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study.
J Thorac Oncol. 2009;4:512-7.
PubMed Text format Related articles Abstract available

YANG P , Mandrekar SJ, Hillman SH, Allen Ziegler KL, et al
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study.
J Thorac Oncol. 2009;4:479-85.
PubMed Text format Related articles Abstract available

HUANG CT , Hong RL
Nasion swelling as the presenting symptom of lung adenocarcinoma.
J Thorac Oncol. 2009;4:555-8.
PubMed Text format Related articles Abstract available

WANG J , Sun H, Bai R, Liu H, et al
Pulmonary blastoma with endobronchial growth.
J Thorac Oncol. 2009;4:543-4.
PubMed Text format Related articles

March 2009

DONNEM T , Al-Shibli K, Al-Saad S, Busund LT, et al
Prognostic Impact of Fibroblast Growth Factor 2 in Non-small Cell Lung Cancer: Coexpression with VEGFR-3 and PDGF-B Predicts Poor Survival.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

TEMEL JS , Greer JA, Goldberg S, Vogel PD, et al
A Structured Exercise Program for Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KASYMJANOVA G , Correa JA, Kreisman H, Dajczman E, et al
Prognostic Value of the Six-Minute Walk in Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

KRUPITSKAYA Y , Eslamy HK, Nguyen DD, Kumar A, et al
Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy.
J Thorac Oncol. 2009;4:429-31.
PubMed Text format Related articles Abstract available

VARELLA-GARCIA M , Mitsudomi T, Yatabe Y, Kosaka T, et al
EGFR and HER2 Genomic Gain in Recurrent Non-small Cell Lung Cancer After Surgery: Impact on Outcome to Treatment with Gefitinib and Association with EGFR and KRAS Mutations in a Japanese Cohort.
J Thorac Oncol. 2009;4:318-25.
PubMed Text format Related articles Abstract available

SEQUIST LV , Nagrath S, Toner M, Haber DA, et al
The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients.
J Thorac Oncol. 2009;4:281-3.
PubMed Text format Related articles Abstract available

MANNINO DM
COPD and Lung Cancer Among Women: An Equal Opportunity Risk?
J Thorac Oncol. 2009;4:275-6.
PubMed Text format Related articles

JIANG J , Zhou J, Shen Y
Acute myeloblastic leukemia with initial manifestations in the central airway.
J Thorac Oncol. 2009;4:409-10.
PubMed Text format Related articles

WURTZ A , Benhamed L, Conti M, Bouchindhomme B, et al
Results of systematic nodal dissection in typical and atypical carcinoid tumors of the lung.
J Thorac Oncol. 2009;4:388-94.
PubMed Text format Related articles Abstract available

DETTERBECK F
What is quality and does it matter?
J Thorac Oncol. 2009;4:279-80.
PubMed Text format Related articles

February 2009

RENOUF DJ , Wood-Baker R, Ionescu DN, Leung S, et al
BCL-2 Expression is Prognostic for Improved Survival in Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

PURNELL PR , Mack PC, Tepper CG, Evans CP, et al
The Src Inhibitor AZD0530 Blocks Invasion and May Act as a Radiosensitizer in Lung Cancer Cells.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

VLASTOS F , Lacomme S, Wild P, Poulain S, et al
Do Evolving Practices Improve Survival in Operated Lung Cancer Patients? A Biobank May Answer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

HORN L , Bernardo P, Sandler A, Wagner H, et al
A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

PITZ MW , Musto G, Demers AA, Kliewer EV, et al
Survival and Treatment Pattern of Non-small Cell Lung Cancer Over 20 Years.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

ANDERSEN S , Donnem T, Al-Saad S, Al-Shibli K, et al
Angiogenic Markers Show High Prognostic Impact on Survival in Marginally Operable Non-small Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SLATORE CG , Au DH, Hollingworth W
Cost-Effectiveness of a Smoking Cessation Program Implemented at the Time of Surgery for Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

CAPPUZZO F , Varella-Garcia M, Rossi E, Gajapathy S, et al
MYC and EIF3H Coamplification Significantly Improve Response and Survival of Non-small Cell Lung Cancer Patients (NSCLC) Treated with Gefitinib.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SRIVASTAVA G , Rana V, Wallace S, Taylor S, et al
Risk of Intracranial Hemorrhage and Cerebrovascular Accidents in Non-small Cell Lung Cancer Brain Metastasis Patients.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

SCHWARTZ AG , Cote ML, Wenzlaff AS, Van Dyke A, et al
Chronic Obstructive Lung Diseases and Risk of Non-small Cell Lung Cancer in Women.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

BORGIA JA , Basu S, Faber LP, Kim AW, et al
Establishment of a Multi-Analyte Serum Biomarker Panel to Identify Lymph Node Metastases in Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

YOHENA T , Yoshino I, Takenaka T, Kameyama T, et al
Upregulation of Hypoxia-Inducible Factor-1alpha mRNA and its Clinical Significance in Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

HOTTA K , Fujiwara Y, Matsuo K, Kiura K, et al
Time to Progression as a Surrogate Marker for Overall Survival in Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

IGISHI T , Shigeoka Y, Yasuda K, Suyama H, et al
UFT Plus Vinorelbine in Advanced Non-small Cell Lung Cancer: A Phase I and an Elderly Patient-Directed Phase II Study.
J Thorac Oncol. 2009.
PubMed Text format Related articles Abstract available

UM SJ , Park BH, Son C
An aortoesophageal fistula in patient with lung cancer after chemo-irradiation and subsequent esophageal stent implantation.
J Thorac Oncol. 2009;4:263-5.
PubMed Text format Related articles Abstract available

AL HUSAINI H , Wheatley-Price P, Clemons M, Shepherd FA, et al
Prevention and management of bone metastases in lung cancer: a review.
J Thorac Oncol. 2009;4:251-9.
PubMed Text format Related articles Abstract available

STINCHCOMBE TE , Socinski MA
Treatment Paradigms for Advanced Stage Non-small Cell Lung Cancer in the Era of Multiple Lines of Therapy.
J Thorac Oncol. 2009;4:243-50.
PubMed Text format Related articles Abstract available

BUYS TP , Aviel-Ronen S, Waddell TK, Lam WL, et al
Defining Genomic Alteration Boundaries for a Combined Small Cell and Non-small Cell Lung Carcinoma.
J Thorac Oncol. 2009;4:227-239.
PubMed Text format Related articles Abstract available

GOVINDAN R , Wang X, Baggstrom MQ, Burdette-Radoux S, et al
A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer: CALGB 30104.
J Thorac Oncol. 2009;4:220-226.
PubMed Text format Related articles Abstract available

AKERLEY W , Boucher KM, Bentz JS, Arbogast K, et al
A Phase II Study of Erlotinib as Initial Treatment for Patients with Stage IIIB-IV Non-small Cell Lung Cancer.
J Thorac Oncol. 2009;4:214-219.
PubMed Text format Related articles Abstract available

KAWAISHI M , Fujiwara Y, Fukui T, Kato T, et al
Circulating Endothelial Cells in Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel.
J Thorac Oncol. 2009;4:208-213.
PubMed Text format Related articles Abstract available

OKUBO K , Bando T, Miyahara R, Sakai H, et al
Resection of Pulmonary Metastasis of Non-small Cell Lung Cancer.
J Thorac Oncol. 2009;4:203-7.
PubMed Text format Related articles Abstract available

LIPTAY MJ , D'amico TA, Nwogu C, Demmy TL, et al
Intraoperative Sentinel Node Mapping with Technitium-99 in Lung Cancer: Results of CALGB 140203 Multicenter Phase II Trial.
J Thorac Oncol. 2009;4:198-202.
PubMed Text format Related articles Abstract available

SUEMITSU R , Takeo S, Hamatake M, Yoshino J, et al
The perioperative complications for elderly patients with lung cancer associated with a pulmonary resection under general anesthesia.
J Thorac Oncol. 2009;4:193-7.
PubMed Text format Related articles Abstract available

GAYED IW , Liu HH, Wei X, Liao Z, et al
Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer.
J Thorac Oncol. 2009;4:179-84.
PubMed Text format Related articles Abstract available

CHIEN CR , Chen TH
A bayesian model for age, period, and cohort effects on mortality trends for lung cancer, in association with gender-specific incidence and case-fatality rates.
J Thorac Oncol. 2009;4:167-71.
PubMed Text format Related articles Abstract available

ZHANG W , Peyton M, Xie Y, Soh J, et al
Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines.
J Thorac Oncol. 2009;4:161-166.
PubMed Text format Related articles Abstract available

TANVETYANON T , Murtagh R, Bepler G
Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab.
J Thorac Oncol. 2009;4:268-9.
PubMed Text format Related articles

PASTORINO U , Calabro E, Tamborini E, Marchiano A, et al
Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib.
J Thorac Oncol. 2009;4:266-7.
PubMed Text format Related articles Abstract available

ANTONI DN , Jeung MY, Mennecier B, Ruppert AM, et al
A two-faced young woman.
J Thorac Oncol. 2009;4:240-1.
PubMed Text format Related articles

DEMIR A , Gunluoglu MZ, Dagoglu N, Turna A, et al
Surgical treatment and prognosis of primitive neuroectodermal tumors of the thorax.
J Thorac Oncol. 2009;4:185-92.
PubMed Text format Related articles Abstract available

CHAN HP , Tran V, Lewis C, Thomas PS, et al
Elevated levels of oxidative stress markers in exhaled breath condensate.
J Thorac Oncol. 2009;4:172-8.
PubMed Text format Related articles Abstract available

January 2009

SINGH N , Aggarwal AN
Current Approach to Treatment of Non-small Cell Lung Cancer in Developing Countries-Time for a Rethink?
J Thorac Oncol. 2009;4:143-4.
PubMed Text format Related articles

CARDONA AF , Reguart N, Reveiz L
Wood-Smoke Exposure (WSE) as a Predictor of Response and Survival in Erlotinib-Treated Non-small Cell Lung Cancer (NSCLC) Patients.
J Thorac Oncol. 2009;4:142-143.
PubMed Text format Related articles

PRUDKIN L , Tang X, Wistuba II
Germ-Line and Somatic Presentations of the EGFR T790M Mutation in Lung Cancer.
J Thorac Oncol. 2009;4:139-41.
PubMed Text format Related articles

DE PAS T , Spitaleri G, Pelosi G, De Carlis L, et al
Erlotinib Combined with Cyclosporine in a Liver-Transplant Recipient with Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.
J Thorac Oncol. 2009;4:138-139.
PubMed Text format Related articles

ORCURTO MV , Delaloye AB, Letovanec I, Martins Favre M, et al
Detection of an Asymptomatic Right-Ventricle Cardiac Metastasis from a Small-Cell Lung Cancer by F-18-FDG PET/CT.
J Thorac Oncol. 2009;4:127-30.
PubMed Text format Related articles Abstract available

BEANE J , Spira A, Lenburg ME
Clinical impact of high-throughput gene expression studies in lung cancer.
J Thorac Oncol. 2009;4:109-18.
PubMed Text format Related articles Abstract available

JALAL S , Ansari R, Govindan R, Bhatia S, et al
Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study.
J Thorac Oncol. 2009;4:93-96.
PubMed Text format Related articles Abstract available

DAVIES AM , Chansky K, Lara PN Jr, Gumerlock PH, et al
Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339).
J Thorac Oncol. 2009;4:87-92.
PubMed Text format Related articles Abstract available

CHOY H , Jain AK, Moughan J, Curran W, et al
RTOG 0017: A Phase I Trial of Concurrent Gemcitabine/Carboplatin or Gemcitabine/Paclitaxel and Radiation Therapy ("Ping-Pong Trial") Followed By Adjuvant Chemotherapy for Patients with Favorable Prognosis Inoperable Stage IIIA/B Non-small Cell Lung Cance
J Thorac Oncol. 2009;4:80-86.
PubMed Text format Related articles Abstract available

LEE CB , Stinchcombe TE, Moore DT, Morris DE, et al
Late Complications of High-Dose (>/=66 Gy) Thoracic Conformal Radiation Therapy in Combined Modality Trials in Unresectable Stage III Non-small Cell Lung Cancer.
J Thorac Oncol. 2009;4:74-79.
PubMed Text format Related articles Abstract available

HSIE M , Morbidini-Gaffney S, Kohman LJ, Dexter E, et al
Definitive treatment of poor-risk patients with stage I lung cancer: a single institution experience.
J Thorac Oncol. 2009;4:69-73.
PubMed Text format Related articles Abstract available

DE LEYN P , Vansteenkiste J, Lievens Y, Van Raemdonck D, et al
Survival after Trimodality Treatment for Superior Sulcus and Central T4 Non-small Cell Lung Cancer.
J Thorac Oncol. 2009;4:62-8.
PubMed Text format Related articles Abstract available

FOROULIS CN , Lioulias AG, Papakonstantinou C
Simple laboratory parameters which can determine the clinical state of patients after pneumonectomy for lung cancer.
J Thorac Oncol. 2009;4:55-61.
PubMed Text format Related articles Abstract available

OU SH , Ziogas A, Zell JA
Prognostic Factors for Survival in Extensive Stage Small Cell Lung Cancer (ED-SCLC): The Importance of Smoking History, Socioeconomic and Marital Statuses, and Ethnicity.
J Thorac Oncol. 2009;4:37-43.
PubMed Text format Related articles Abstract available

WU C , Hao H, Li L, Zhou X, et al
Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients.
J Thorac Oncol. 2009;4:30-36.
PubMed Text format Related articles Abstract available

LIM EH , Zhang SL, Li JL, Yap WS, et al
Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC).
J Thorac Oncol. 2009;4:12-21.
PubMed Text format Related articles Abstract available

SUDA K , Onozato R, Yatabe Y, Mitsudomi T, et al
EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
J Thorac Oncol. 2009;4:1-4.
PubMed Text format Related articles Abstract available

SHIN S , Kim KJ, Lee YJ, Choi HJ, et al
Complete response of recurrent squamous cell carcinoma of the lung: dose the dose matter?
J Thorac Oncol. 2009;4:141-2.
PubMed Text format Related articles

DARTNELL J , Pilling J, Ferner R, Cane P, et al
Malignant triton tumor of the brachial plexus invading the left thoracic inlet: a rare differential diagnosis of pancoast tumor.
J Thorac Oncol. 2009;4:135-7.
PubMed Text format Related articles Abstract available

HIMPE U , Deroose CM, Leyn PD, Verbeken E, et al
Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
J Thorac Oncol. 2009;4:107-8.
PubMed Text format Related articles Abstract available

EDELL E , Lam S, Pass H, Miller YE, et al
Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial.
J Thorac Oncol. 2009;4:49-54.
PubMed Text format Related articles Abstract available

RINTOUL RC , Tournoy KG, El Daly H, Carroll NR, et al
EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience.
J Thorac Oncol. 2009;4:44-8.
PubMed Text format Related articles Abstract available

KOSAKA T , Yatabe Y, Onozato R, Kuwano H, et al
Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma.
J Thorac Oncol. 2009;4:22-9.
PubMed Text format Related articles Abstract available

ONOZATO R , Kosaka T, Kuwano H, Sekido Y, et al
Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.
J Thorac Oncol. 2009;4:5-11.
PubMed Text format Related articles Abstract available

December 2008

HIRSCH FR , Spreafico A, Novello S, Wood MD, et al
The Prognostic and Predictive Role of Histology in Advanced Non-small Cell Lung Cancer: A Literature Review.
J Thorac Oncol. 2008;3:1468-1481.
PubMed Text format Related articles Abstract available

SCHNEIDER BJ , Kalemkerian GP, Kraut MJ, Wozniak AJ, et al
Phase II Study of Celecoxib and Docetaxel in Non-small Cell Lung Cancer (NSCLC) Patients with Progression after Platinum-Based Therapy.
J Thorac Oncol. 2008;3:1454-1459.
PubMed Text format Related articles Abstract available

SCHNEIDER CP , Heigener D, Schott-von-Romer K, Gutz S, et al
Epidermal Growth Factor Receptor-Related Tumor Markers and Clinical Outcomes with Erlotinib in Non-small Cell Lung Cancer: An Analysis of Patients from German Centers in the TRUST Study.
J Thorac Oncol. 2008;3:1446-1453.
PubMed Text format Related articles Abstract available

KUBOTA K , Nishiwaki Y, Tamura T, Nakagawa K, et al
Efficacy and Safety of Erlotinib Monotherapy for Japanese Patients with Advanced Non-small Cell Lung Cancer: A Phase II Study.
J Thorac Oncol. 2008;3:1439-1445.
PubMed Text format Related articles Abstract available

NOMORI H , Shibata H, Uno K, Iyama K, et al
11C-Acetate can be Used in Place of 18F-Fluorodeoxyglucose for Positron Emission Tomography Imaging of Non-small Cell Lung Cancer with Higher Sensitivity for Well-Differentiated Adenocarcinoma.
J Thorac Oncol. 2008;3:1427-1432.
PubMed Text format Related articles Abstract available

LEE JG , Lee CY, Bae MK, Park IK, et al
Validity of International Association for the Study of Lung Cancer Proposals for the Revision of N Descriptors in Lung Cancer.
J Thorac Oncol. 2008;3:1421-1426.
PubMed Text format Related articles Abstract available

KASHIWABARA K , Saeki S, Sasaki JI, Nomura M, et al
Combined Evaluation of Postoperative Serum Levels of Carcinoembryonic Antigen Less than or Equal to 2.5 ng/ml and Absence of Vascular Invasion may Predict no Recurrence of Stage I Adenocarcinoma Lung Cancer.
J Thorac Oncol. 2008;3:1416-1420.
PubMed Text format Related articles Abstract available

BERTHILLER J , Straif K, Boniol M, Voirin N, et al
Cannabis Smoking and Risk of Lung Cancer in Men: A Pooled Analysis of Three Studies in Maghreb.
J Thorac Oncol. 2008;3:1398-1403.
PubMed Text format Related articles Abstract available

RAZ DJ , Gomez SL, Chang ET, Kim JY, et al
Epidemiology of Non-small Cell Lung Cancer in Asian Americans: Incidence Patterns Among Six Subgroups by Nativity.
J Thorac Oncol. 2008;3:1391-1397.
PubMed Text format Related articles Abstract available

TRAVIS WD , Brambilla E, Rami-Porta R, Vallieres E, et al
Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer.
J Thorac Oncol. 2008;3:1384-1390.
PubMed Text format Related articles Abstract available

OTSUKA S , Bebb G
The CXCR4/SDF-1 Chemokine Receptor Axis: A New Target Therapeutic for Non-small Cell Lung Cancer.
J Thorac Oncol. 2008;3:1379-1383.
PubMed Text format Related articles Abstract available

KRIDEL R , Myit S, Pache JC, Gaspoz JM, et al
Pulmonary tumor embolism: a rare cause of acute right heart failure with elevated D-dimers.
J Thorac Oncol. 2008;3:1482-3.
PubMed Text format Related articles Abstract available

TURNER JF JR , Samlowski W, Bilodeau LL
Image of the month. Hemoptysis in a patient with melanoma and pulmonary infiltrates.
J Thorac Oncol. 2008;3:1466-7.
PubMed Text format Related articles

MUIRHEAD R , McNee SG, Featherstone C, Moore K, et al
Use of Maximum Intensity Projections (MIPs) for target outlining in 4DCT radiotherapy planning.
J Thorac Oncol. 2008;3:1433-8.
PubMed Text format Related articles Abstract available

SKOV BG , Krasnik M, Lantuejoul S, Skov T, et al
Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival.
J Thorac Oncol. 2008;3:1410-5.
PubMed Text format Related articles Abstract available

MINAI OA , Shah S, Mazzone P, Budev MM, et al
Bronchogenic carcinoma after lung transplantation: characteristics and outcomes.
J Thorac Oncol. 2008;3:1404-9.
PubMed Text format Related articles Abstract available

ARCASOY SM
Controversies in bronchogenic carcinoma following lung transplantation: type of transplant operation and role of screening.
J Thorac Oncol. 2008;3:1377-8.
PubMed Text format Related articles

MANDREKAR JN , Mandrekar SJ
Case-control study design: what, when, and why?
J Thorac Oncol. 2008;3:1371-2.
PubMed Text format Related articles

November 2008

KIM YM , Nam HS, Kim CH, Choe du H, et al
ST segment elevation and T wave inversion on electrocardiograms 2 years after surgery for lung cancer.
J Thorac Oncol. 2008;3:1363-4.
PubMed Text format Related articles

MEYER J , Wahidi M, Shofer S, Evans J, et al
Formation of a bronchoesophageal fistula following concurrent radiation and chemotherapy for lung cancer in the setting of Behcet's disease.
J Thorac Oncol. 2008;3:1361-2.
PubMed Text format Related articles

ERICKSON TM , Koeppe JR, Miller YE, Stuart RW, et al
Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: a diagnosis worth making.
J Thorac Oncol. 2008;3:1353-5.
PubMed Text format Related articles Abstract available

WEISS GJ , Kingsley C
Pathway targets to explore in the treatment of non-small cell lung cancer.
J Thorac Oncol. 2008;3:1342-52.
PubMed Text format Related articles Abstract available

SCHNEIDER J , Hoffmann H, Dienemann H, Herth FJ, et al
Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer.
J Thorac Oncol. 2008;3:1317-24.
PubMed Text format Related articles Abstract available

SOCINSKI MA , Raju RN, Neubauer M, Smith DA, et al
Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
J Thorac Oncol. 2008;3:1308-16.
PubMed Text format Related articles Abstract available

STINCHCOMBE TE , Mauer AM, Hodgson LD, Herndon JE 2nd, et al
Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.
J Thorac Oncol. 2008;3:1301-7.
PubMed Text format Related articles Abstract available

GADGEEL SM , Wozniak A, Ruckdeschel JC, Heilbrun LK, et al
Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer.
J Thorac Oncol. 2008;3:1293-300.
PubMed Text format Related articles Abstract available

BORGHAEI H , Langer CJ, Millenson M, Ruth KJ, et al
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017.
J Thorac Oncol. 2008;3:1286-92.
PubMed Text format Related articles Abstract available

STINCHCOMBE TE , Lee CB, Moore DT, Rivera MP, et al
Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.
J Thorac Oncol. 2008;3:1279-85.
PubMed Text format Related articles Abstract available

YOUNIS T , Al-Fayea T, Virik K, Morzycki W, et al
Adjuvant chemotherapy uptake in non-small cell lung cancer.
J Thorac Oncol. 2008;3:1272-8.
PubMed Text format Related articles Abstract available

LIM E , Belcher E, Yap YK, Nicholson AG, et al
The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate.
J Thorac Oncol. 2008;3:1267-71.
PubMed Text format Related articles Abstract available

HIRAMATSU M , Inagaki T, Inagaki T, Matsui Y, et al
Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth.
J Thorac Oncol. 2008;3:1245-50.
PubMed Text format Related articles Abstract available

MOLINA-VILA MA , Bertran-Alamillo J, Reguart N, Taron M, et al
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells.
J Thorac Oncol. 2008;3:1224-35.
PubMed Text format Related articles Abstract available

TRAVIS WD , Giroux DJ, Chansky K, Crowley J, et al
The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
J Thorac Oncol. 2008;3:1213-23.
PubMed Text format Related articles Abstract available

BALL D
Extracranial stereotactic body radiotherapy for stage I non-small cell lung cancer: still investigational or standard of care?
J Thorac Oncol. 2008;3:1209-10.
PubMed Text format Related articles

ICHIHARA E , Tabata M, Takigawa N, Sato Y, et al
Synchronous pulmonary MALT lymphoma and pulmonary adenocarcinoma after metachronous gastric MALT lymphoma and gastric adenocarcinoma.
J Thorac Oncol. 2008;3:1362-3.
PubMed Text format Related articles

DAHELE M , Pearson S, Purdie T, Bissonnette JP, et al
Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center.
J Thorac Oncol. 2008;3:1332-41.
PubMed Text format Related articles Abstract available

INTERNULLO E , Cassivi SD, Van Raemdonck D, Friedel G, et al
Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons.
J Thorac Oncol. 2008;3:1257-66.
PubMed Text format Related articles Abstract available

ALBERTUS DL , Seder CW, Chen G, Wang X, et al
AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma.
J Thorac Oncol. 2008;3:1236-44.
PubMed Text format Related articles Abstract available

October 2008

HUNG KS , Lee CN, Liu HE
Rapid detection of hotspot mutations in epidermal growth factor receptor by polymerase chain reaction facilitates the management of non-small cell lung cancer.
J Thorac Oncol. 2008;3:1202-3.
PubMed Text format Related articles

SHVARTSBEYN M , Edelman MJ
Pemetrexed-induced typhlitis in non-small cell lung cancer.
J Thorac Oncol. 2008;3:1188-90.
PubMed Text format Related articles Abstract available

WHEATLEY-PRICE P , Shepherd FA
Targeting angiogenesis in the treatment of lung cancer.
J Thorac Oncol. 2008;3:1173-84.
PubMed Text format Related articles Abstract available

EBI N , Semba H, Tokunaga SJ, Takayama K, et al
A phase II trial of gefitinib monotherapy in chemotherapy-naive patients of 75 years or older with advanced non-small cell lung cancer.
J Thorac Oncol. 2008;3:1166-71.
PubMed Text format Related articles Abstract available

MILLER AA , Wang XF, Gu L, Hoffman P, et al
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
J Thorac Oncol. 2008;3:1159-65.
PubMed Text format Related articles Abstract available

HEIST RS , Fidias P, Huberman M, Ardman B, et al
A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer.
J Thorac Oncol. 2008;3:1153-8.
PubMed Text format Related articles Abstract available

BARLESI F , Barrau K, Loundou A, Doddoli C, et al
Impact of information on quality of life and satisfaction of non-small cell lung cancer patients: a randomized study of standardized versus individualized information before thoracic surgery.
J Thorac Oncol. 2008;3:1146-52.
PubMed Text format Related articles Abstract available

CHEN L , Antras L, Duh MS, Neary M, et al
Symptom assessment in relapsed small cell lung cancer: cross-validation of the patient symptom assessment in lung cancer instrument.
J Thorac Oncol. 2008;3:1137-45.
PubMed Text format Related articles Abstract available

DAJCZMAN E , Kasymjanova G, Kreisman H, Swinton N, et al
Should patient-rated performance status affect treatment decisions in advanced lung cancer?
J Thorac Oncol. 2008;3:1133-6.
PubMed Text format Related articles Abstract available

HANAGIRI T , Sugio K, Mizukami M, Ichiki Y, et al
Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer.
J Thorac Oncol. 2008;3:1127-32.
PubMed Text format Related articles Abstract available

CHAKRA M , Pujol JL, Lamy PJ, Bozonnat MC, et al
Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
J Thorac Oncol. 2008;3:1119-26.
PubMed Text format Related articles Abstract available

BEPLER G , Sommers KE, Cantor A, Li X, et al
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.
J Thorac Oncol. 2008;3:1112-8.
PubMed Text format Related articles Abstract available

TISEO M , Capelletti M, De Palma G, Franciosi V, et al
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.
J Thorac Oncol. 2008;3:1104-11.
PubMed Text format Related articles Abstract available

KAWADA I , Soejima K, Watanabe H, Nakachi I, et al
An alternative method for screening EGFR mutation using RFLP in non-small cell lung cancer patients.
J Thorac Oncol. 2008;3:1096-103.
PubMed Text format Related articles Abstract available

FERNANDEZ-GARCIA I , Ortiz-de-Solorzano C, Montuenga LM
Telomeres and telomerase in lung cancer.
J Thorac Oncol. 2008;3:1085-8.
PubMed Text format Related articles Abstract available

VAN SCHIL PE
Selection or work-up bias: a recurrent caveat in evaluation of new diagnostic modalities.
J Thorac Oncol. 2008;3:1202.
PubMed Text format Related articles

LIM E , Goldstraw P, Nicholson AG, Travis WD, et al
Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.
J Thorac Oncol. 2008;3:1194-201.
PubMed Text format Related articles Abstract available

ARCHIE PH , Beasley MB, Ross HJ
Biphasic pulmonary blastoma with germ cell differentiation in a 36-year-old man.
J Thorac Oncol. 2008;3:1185-7.
PubMed Text format Related articles Abstract available

CHOONG NW , Hellman RS
Recurrent laryngeal nerve palsy on integrated positron emission tomography-computed tomography.
J Thorac Oncol. 2008;3:1172.
PubMed Text format Related articles

September 2008

SINGH N , Aggarwal AN
Docetaxel as second line therapy in advanced non-small cell lung cancer-the dose and combination may matter!
J Thorac Oncol. 2008;3:1078-9.
PubMed Text format Related articles

WONG AS , Seto KY, Chin TM, Soo RA, et al
Lung cancer response to gefitinib, then erlotinib, then gefitinib again.
J Thorac Oncol. 2008;3:1077-8.
PubMed Text format Related articles

TAKEZAWA K , Okamoto I, Fukuoka M, Nakagawa K, et al
Pharmacokinetic analysis of carboplatin and etoposide in a small cell lung cancer patient undergoing hemodialysis.
J Thorac Oncol. 2008;3:1073-5.
PubMed Text format Related articles Abstract available

BRANDES JC , Schmidt E, Yung R
Occlusive endobronchial stent placement as a novel management approach to massive hemoptysis from lung cancer.
J Thorac Oncol. 2008;3:1071-2.
PubMed Text format Related articles Abstract available

KAIRA K , Ishizuka T, Tanaka H, Tanaka Y, et al
Lung cancer producing granulocyte colony-stimulating factor and rapid spreading to peritoneal cavity.
J Thorac Oncol. 2008;3:1054-5.
PubMed Text format Related articles Abstract available

LIND JS , Smit EF, Grunberg K, Senan S, et al
Fatal interstitial lung disease after erlotinib for non-small cell lung cancer.
J Thorac Oncol. 2008;3:1050-3.
PubMed Text format Related articles Abstract available

HAN JY , Kim HT, Lim KY, Yoon SJ, et al
Randomized phase II study of maintenance irinotecan therapy versus observation following induction chemotherapy with irinotecan and cisplatin in extensive disease small cell lung cancer.
J Thorac Oncol. 2008;3:1039-45.
PubMed Text format Related articles Abstract available

HUANG CH , Millenson MM, Sherman EJ, Borghaei H, et al
Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapy.
J Thorac Oncol. 2008;3:1032-8.
PubMed Text format Related articles Abstract available

HESKETH PJ , Chansky K, Wozniak AJ, Hirsch FR, et al
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.
J Thorac Oncol. 2008;3:1026-31.
PubMed Text format Related articles Abstract available

ATTIA S , Traynor AM, Kim K, Merchant JJ, et al
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.
J Thorac Oncol. 2008;3:1018-25.
PubMed Text format Related articles Abstract available

ATAGI S , Kawahara M, Kusunoki Y, Takada M, et al
Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancer.
J Thorac Oncol. 2008;3:1012-7.
PubMed Text format Related articles Abstract available

CHOONG NW , Mauer AM, Haraf DJ, Lester E, et al
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
J Thorac Oncol. 2008;3:1003-11.
PubMed Text format Related articles Abstract available

KRZAKOWSKI M , Provencio M, Utracka-Hutka B, Villa E, et al
Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
J Thorac Oncol. 2008;3:994-1002.
PubMed Text format Related articles Abstract available

YENDAMURI S , Vaporciyan AA, Zaidi T, Feng L, et al
3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).
J Thorac Oncol. 2008;3:979-84.
PubMed Text format Related articles Abstract available

VESSELLE H , Salskov A, Turcotte E, Wiens L, et al
Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
J Thorac Oncol. 2008;3:971-8.
PubMed Text format Related articles Abstract available

DONNEM T , Al-Saad S, Al-Shibli K, Andersen S, et al
Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
J Thorac Oncol. 2008;3:963-70.
PubMed Text format Related articles Abstract available

POWELL AA , Schultz EM, Ordin DL, Enderle MA, et al
Timeliness across the continuum of care in veterans with lung cancer.
J Thorac Oncol. 2008;3:951-7.
PubMed Text format Related articles Abstract available

TORRINGTON KG
Lung cancer-elapsed time from suspicious radiograph to treatment: how fast is fast enough?
J Thorac Oncol. 2008;3:947-8.
PubMed Text format Related articles

GOODGAME B , Veeramachaneni N, Patterson A, Govindan R, et al
Tracheo-esophageal fistula with bevacizumab after mediastinal radiation.
J Thorac Oncol. 2008;3:1080-1.
PubMed Text format Related articles

SHIONO S , Kawamura M, Sato T, Nakagawa K, et al
Disease-free interval length correlates to prognosis of patients who underwent metastasectomy for esophageal lung metastases.
J Thorac Oncol. 2008;3:1046-9.
PubMed Text format Related articles Abstract available

LYONS G , Quadrelli S, Silva C, Vera K, et al
Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.
J Thorac Oncol. 2008;3:989-93.
PubMed Text format Related articles Abstract available

NAKAJIMA T , Yasufuku K, Fujiwara T, Chiyo M, et al
Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrapulmonary lesions.
J Thorac Oncol. 2008;3:985-8.
PubMed Text format Related articles Abstract available

SAKAO Y , Miyamoto H, Oh S, Takahashi N, et al
The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status.
J Thorac Oncol. 2008;3:958-62.
PubMed Text format Related articles Abstract available

August 2008

CLEMENT-DUCHNE C , Carnin C, Martinet Y
Too restrictive exclusion criteria in advanced stage lung cancer therapeutic trials: are we missing the target?
J Thorac Oncol. 2008;3:943.
PubMed Text format Related articles

NAMAZI H
Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity: a novel molecular mechanism.
J Thorac Oncol. 2008;3:943-4.
PubMed Text format Related articles

GOVINDAN R , Bogart J, Vokes EE
Locally advanced non-small cell lung cancer: the past, present, and future.
J Thorac Oncol. 2008;3:917-28.
PubMed Text format Related articles Abstract available

VASILE E , Tibaldi C, Chella A, Falcone A, et al
Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib.
J Thorac Oncol. 2008;3:912-4.
PubMed Text format Related articles Abstract available

SORENSEN M , Lassen U, Jensen PB, Osterlind K, et al
Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease.
J Thorac Oncol. 2008;3:902-6.
PubMed Text format Related articles Abstract available

ZATLOUKAL P , Gervais R, Vansteenkiste J, Bosquee L, et al
Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer.
J Thorac Oncol. 2008;3:894-901.
PubMed Text format Related articles Abstract available

ARRIETA O , Martinez-Barrera L, Trevino S, Guzman E, et al
Wood-smoke exposure as a response and survival predictor in erlotinib-treated non-small cell lung cancer patients: an open label phase II study.
J Thorac Oncol. 2008;3:887-93.
PubMed Text format Related articles Abstract available

OU SH , Zell JA
Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.
J Thorac Oncol. 2008;3:880-6.
PubMed Text format Related articles Abstract available

VINOD SK , O'Connell DL, Simonella L, Delaney GP, et al
Gaps in optimal care for lung cancer.
J Thorac Oncol. 2008;3:871-9.
PubMed Text format Related articles Abstract available

SAINT-JACQUES N , Rayson D, Al-Fayea T, Virik K, et al
Waiting times in early-stage non-small cell lung cancer (NSCLC).
J Thorac Oncol. 2008;3:865-70.
PubMed Text format Related articles Abstract available

GAYED IW , Chang J, Kim EE, Nunez R, et al
Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation.
J Thorac Oncol. 2008;3:858-64.
PubMed Text format Related articles Abstract available

JACOT W , Lhermitte L, Dossat N, Pujol JL, et al
Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
J Thorac Oncol. 2008;3:840-50.
PubMed Text format Related articles Abstract available

MURRAY S , Dahabreh IJ, Linardou H, Manoloukos M, et al
Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical database.
J Thorac Oncol. 2008;3:832-9.
PubMed Text format Related articles Abstract available

YOULDEN DR , Cramb SM, Baade PD
The International Epidemiology of Lung Cancer: geographical distribution and secular trends.
J Thorac Oncol. 2008;3:819-31.
PubMed Text format Related articles Abstract available

DZIADZIUSZKO R , Camidge DR, Hirsch FR
The insulin-like growth factor pathway in lung cancer.
J Thorac Oncol. 2008;3:815-8.
PubMed Text format Related articles Abstract available

HANNA N
Unlocking the biological clues of lung cancer.
J Thorac Oncol. 2008;3:809-10.
PubMed Text format Related articles

HWANG SW , Han HS, Lim KY, Han JY, et al
Drug interaction between complementary herbal medicines and gefitinib.
J Thorac Oncol. 2008;3:942-3.
PubMed Text format Related articles

NAKAZATO Y , Tanaka R, Seki E, Iijima M, et al
Differential diagnosis of primary versus metastatic pulmonary adenocarcinomas using gene mutation analyses: a case report.
J Thorac Oncol. 2008;3:931-4.
PubMed Text format Related articles Abstract available

PENEL N , Taieb S, Ceugnart L, Dansin E, et al
Report of eight recent cases of locally advanced primary pulmonary artery sarcomas: failure of Doxorubicin-based chemotherapy.
J Thorac Oncol. 2008;3:907-11.
PubMed Text format Related articles Abstract available

July 2008

MARKS JL , Golas B, Kirchoff T, Miller VA, et al
EGFR mutant lung adenocarcinomas in patients with germline BRCA mutations.
J Thorac Oncol. 2008;3:805.
PubMed Text format Related articles

AOKAGE K , Yoshida J, Ishii G, Takahashi S, et al
Long-term survival in two cases of resected gastric metastasis of pulmonary pleomorphic carcinoma.
J Thorac Oncol. 2008;3:796-9.
PubMed Text format Related articles Abstract available

KOBAYASHI N , Toyooka S, Ichimura K, Soh J, et al
Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung.
J Thorac Oncol. 2008;3:704-10.
PubMed Text format Related articles Abstract available

MAESHIMA AM , Tochigi N, Tsuta K, Asamura H, et al
Histological evaluation of the effect of smoking on peripheral small adenocarcinomas of the lung.
J Thorac Oncol. 2008;3:698-703.
PubMed Text format Related articles Abstract available

June 2008

STEINFORT D , Irving L
Use of fluoroscopy during endobronchial ultrasonography for transbronchial lung biopsies of peripheral lung lesions.
J Thorac Oncol. 2008;3:685-6.
PubMed Text format Related articles

HAMAD AM , Rizzardi G, Marulli G, Rea F, et al
Nodal recurrence of pulmonary carcinoid 30 years after primary resection.
J Thorac Oncol. 2008;3:680-1.
PubMed Text format Related articles Abstract available

WAGNER M , Besse B, Balleyguier C, Soria JC, et al
Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinoma.
J Thorac Oncol. 2008;3:677-9.
PubMed Text format Related articles

RAO AV , Wilson J, Sylvester K
Pulmonary benign metastasizing leiomyoma following hysterectomy: a clinicopathologic correlation.
J Thorac Oncol. 2008;3:674-6.
PubMed Text format Related articles Abstract available

PACI M , Cavazza A, Ferrari G, Filice A, et al
Image of the month. Pulmonary tuberculosis mimicking lung metastasis.
J Thorac Oncol. 2008;3:660-1.
PubMed Text format Related articles

FLORESCU M , Hasan B, Seymour L, Ding K, et al
A clinical prognostic index for patients treated with erlotinib in National Cancer Institute of Canada Clinical Trials Group study BR.21.
J Thorac Oncol. 2008;3:590-8.
PubMed Text format Related articles Abstract available

ERNST A , Anantham D, Eberhardt R, Krasnik M, et al
Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy.
J Thorac Oncol. 2008;3:577-82.
PubMed Text format Related articles Abstract available

WIGLE DA
The beginning of the end of mediastinoscopy?
J Thorac Oncol. 2008;3:561-2.
PubMed Text format Related articles

Proceedings of the Fifth Cambridge Conference on Novel Agents in the Treatment of Lung Cancer. October 1-2, 2007. Cambridge, Massachusetts, USA.
J Thorac Oncol. 2008;3.
PubMed Text format Related articles

Discussion - EGFR-targeted agents.
J Thorac Oncol. 2008;3.
PubMed Text format Related articles

Discussion - anti-VEGF agents.
J Thorac Oncol. 2008;3.
PubMed Text format Related articles

January 2008

IGNATIUS OU SH , Zell JA
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition.
J Thorac Oncol. 2008.
PubMed Text format Related articles Abstract available

FARJAH F , Flum DR, Ramsey SD, Heagerty PJ, et al
Multi-Modality Mediastinal Staging for Lung Cancer Among Medicare Beneficiaries.
J Thorac Oncol. 2008.
PubMed Text format Related articles Abstract available

VERGNENEGRE A , Tillon J, Corre R, Barlesi F, et al
A Randomized Phase II Trial Assessing in Advanced Non-small Cell Lung Cancer Patients with Stable Disease after Two Courses of Cisplatin-Gemcitabine an Early Modification of Chemotherapy Doublet with Paclitaxel-Gemcitabine Versus Continuation of Cisplati
J Thorac Oncol. 2008.
PubMed Text format Related articles Abstract available

YOSHIMURA N , Kudoh S, Kimura T, Mitsuoka S, et al
Phase II Study of Docetaxel and Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer.
J Thorac Oncol. 2008.
PubMed Text format Related articles Abstract available

KOCH A , Fohlin H, Sorenson S
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy.
J Thorac Oncol. 2008.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: